CN101305019B - 新的环肽化合物 - Google Patents

新的环肽化合物 Download PDF

Info

Publication number
CN101305019B
CN101305019B CN2006800390294A CN200680039029A CN101305019B CN 101305019 B CN101305019 B CN 101305019B CN 2006800390294 A CN2006800390294 A CN 2006800390294A CN 200680039029 A CN200680039029 A CN 200680039029A CN 101305019 B CN101305019 B CN 101305019B
Authority
CN
China
Prior art keywords
compound
salt
brd
reaction
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800390294A
Other languages
English (en)
Chinese (zh)
Other versions
CN101305019A (zh
Inventor
闺正博
吉村诚司
上条一纪
牧野拓也
安田实
山中敏夫
辻井荣作
山岸幸子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of CN101305019A publication Critical patent/CN101305019A/zh
Application granted granted Critical
Publication of CN101305019B publication Critical patent/CN101305019B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN2006800390294A 2005-10-26 2006-10-26 新的环肽化合物 Expired - Fee Related CN101305019B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US73001105P 2005-10-26 2005-10-26
US60/730,011 2005-10-26
US75120405P 2005-12-19 2005-12-19
US60/751,204 2005-12-19
PCT/JP2006/321924 WO2007049803A1 (en) 2005-10-26 2006-10-26 New cyclic peptide compounds

Publications (2)

Publication Number Publication Date
CN101305019A CN101305019A (zh) 2008-11-12
CN101305019B true CN101305019B (zh) 2012-12-12

Family

ID=37847219

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006800390294A Expired - Fee Related CN101305019B (zh) 2005-10-26 2006-10-26 新的环肽化合物

Country Status (17)

Country Link
US (2) US7872097B2 (https=)
EP (1) EP1957518B1 (https=)
JP (1) JP5218051B2 (https=)
KR (1) KR101273681B1 (https=)
CN (1) CN101305019B (https=)
AU (1) AU2006306974B2 (https=)
BR (1) BRPI0617781A2 (https=)
CA (1) CA2623898C (https=)
ES (1) ES2557477T3 (https=)
IL (1) IL190286A0 (https=)
NO (1) NO20082354L (https=)
PL (1) PL1957518T3 (https=)
PT (1) PT1957518E (https=)
RU (1) RU2423377C2 (https=)
TW (1) TWI391403B (https=)
WO (1) WO2007049803A1 (https=)
ZA (1) ZA200803525B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008250254B2 (en) * 2007-05-02 2012-08-16 Astellas Pharma Inc. New cyclic peptide compounds
JP5625910B2 (ja) * 2008-09-24 2014-11-19 アステラス製薬株式会社 ペプチド化合物およびその製造方法
WO2010088573A1 (en) * 2009-01-30 2010-08-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis c infection
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
AU2010248206A1 (en) * 2009-05-15 2011-12-01 Stichting Het Nederlands Kanker Instituut Lysine compounds and their use in site- and chemoselective modification of peptides and proteins
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
KR20120125610A (ko) * 2009-12-30 2012-11-16 싸이넥시스, 인크. 시클로스포린 유사체
WO2014035707A1 (en) * 2012-08-25 2014-03-06 The Johns Hopkins University Gapdh cascade inhibitor compounds and methods of use and treatment of stress induced disorders including mental illness
EP2900684A2 (en) 2012-09-29 2015-08-05 Novartis AG Cyclic peptides and use as medicines
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
WO2015031381A1 (en) 2013-08-26 2015-03-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis c
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271267A (ja) * 1991-04-23 1993-10-19 Fujisawa Pharmaceut Co Ltd Ｆｒ９０１４５９物質、その製法及び用途
PT1091975E (pt) 1998-07-01 2006-05-31 Debiopharm Sa Nova ciclosporina com um perfil de actividade melhorado
AR031010A1 (es) 2000-10-19 2003-09-03 Fujisawa Pharmaceutical Co Una composicion farmaceutica, util para inhibir el dano celular
EP1816138A1 (en) * 2001-10-19 2007-08-08 Isotechnika,Inc. Cyclosporine analogue mixtures and their use as immunomodulating agents
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
JP2007015926A (ja) * 2003-10-06 2007-01-25 Fujisawa Pharmaceut Co Ltd Ｃ型肝炎治療剤
BRPI0515494A (pt) 2004-10-01 2008-07-29 Debiopharm Sa uso de [d-meala] 3-[etval] 4-ciclosporina para o tratamento de infecção por hepatite c e composição farmacêutica compreendendo a referida [d-meala] 3-[etval] 4-ciclosporina
KR101309409B1 (ko) 2004-10-01 2013-09-23 싸이넥시스, 인크. Ｃ형 간염 바이러스 감염의 치료 및 예방을 위한 ３-에테르및 ３-티오에테르 치환된 시클로스포린 유도체
US7696167B2 (en) 2004-11-22 2010-04-13 Astellas Pharma Inc. Cyclic peptide compound

Also Published As

Publication number Publication date
CA2623898A1 (en) 2007-05-03
JP2009513562A (ja) 2009-04-02
US7872097B2 (en) 2011-01-18
EP1957518A1 (en) 2008-08-20
CA2623898C (en) 2013-12-24
IL190286A0 (en) 2011-08-01
RU2008116674A (ru) 2009-10-27
JP5218051B2 (ja) 2013-06-26
TWI391403B (zh) 2013-04-01
NO20082354L (no) 2008-07-01
ES2557477T3 (es) 2016-01-26
PT1957518E (pt) 2016-02-26
BRPI0617781A2 (pt) 2011-08-09
AU2006306974A1 (en) 2007-05-03
AU2006306974B2 (en) 2011-09-22
US20100286033A1 (en) 2010-11-11
WO2007049803A1 (en) 2007-05-03
CN101305019A (zh) 2008-11-12
KR20080065297A (ko) 2008-07-11
EP1957518B1 (en) 2015-12-09
US8252895B2 (en) 2012-08-28
KR101273681B1 (ko) 2013-06-25
ZA200803525B (en) 2009-08-26
TW200732351A (en) 2007-09-01
US20090170755A1 (en) 2009-07-02
RU2423377C2 (ru) 2011-07-10
PL1957518T3 (pl) 2016-07-29

Similar Documents

Publication Publication Date Title
US8252895B2 (en) Cyclic peptide compounds
US10034893B2 (en) 5, 6-D2 uridine nucleoside/tide derivatives
US9603895B2 (en) Cyclosporin analogues for preventing or treating hepatitis C infection
CN103153330B (zh) 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用
KR100555229B1 (ko) Ｃ형 간염 바이러스에 대해 활성인 마크로사이클릭 펩타이드
US8846638B2 (en) Macrocyclic nucleoside phosphoramidate derivatives
US20090047247A1 (en) Pyrrolidine Derivatives
US20090060874A1 (en) Bicyclic pyrrolidine derivatives
WO2011031934A1 (en) Hepatitis c virus inhibitors
CN102617705B (zh) 抑制丙肝病毒复制的大环类化合物
CN105579046A (zh) 用于预防或治疗丙型肝炎的环孢菌素类似物
US20090233972A1 (en) Substituted heterocycles as anti-infectives
US9718851B2 (en) Deuterated nucleoside/tide derivatives
US20090131343A1 (en) Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
WO2016073480A1 (en) Novel cyclosporin analogues for preventing or treating hepatitis c infection
US20090324544A1 (en) Substituted cyclic pyrrolidine derivatives
AU2006200519A1 (en) New compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121212

CF01 Termination of patent right due to non-payment of annual fee